AONC (American Oncology Network) Research & Development: $0 Mil (TTM As of Dec. 2024)


AONC American Oncology Network Inc AONC
20 GF Score
Price $10.00
View Full Analysis

What is American Oncology Network Research & Development?

American Oncology Network AONC 20 Research & Development is $0 Mil as of Dec. 2024. GuruFocus rates AONC with a GF Score™ of 20/100.

Research & Development is the aggregate amount of research and development expenses during the year. American Oncology Network's Research & Development for the three months ended in Dec. 2024 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $0 Mil.

American Oncology Network  (OTCPK:AONC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

American Oncology Network Research & Development Related Terms

American Oncology Network Research & Development Historical Data

* Premium members only.

The historical data trend for American Oncology Network's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network Research & Development Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
0.00 0.00 0.00 0.00 0.00

American Oncology Network Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AONC
20GF Score
American Oncology Network Inc AONC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Oncology Network Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
American Oncology Network (AONC) has a Research & Development of $0 Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on American Oncology Network and its competitors.
Is American Oncology Network's Research & Development too high?
American Oncology Network's current Research & Development is $0 Mil. Overall, American Oncology Network has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does American Oncology Network's Research & Development compare to TOI and AUNA?
American Oncology Network's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on American Oncology Network and its competitors. American Oncology Network's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Oncology Network stock overvalued right now?
American Oncology Network (AONC) has a current Research & Development of $0 Mil. The current Research & Development is $0 Mil. American Oncology Network's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For American Oncology Network (AONC), the current Research & Development is $0 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Oncology Network Business Description

Address 14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913
American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.
20GF Score

Get the complete analysis for AONC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.00
Price